Acibadem Healthcare Group
M.FARUK KÖSE
Prof. M.D.

M.FARUK KÖSE

Medical Units and Clinical Services
  • Gynecologic Oncology
  • Gynecology and Obstetrics
  • Menopause
  • Robotic Rehabilitation
  • Treatment of Endometriosis
  • Treatment of Pelvic Pain
  • Urogynecology

Prof. M. Faruk Köse is a gynecologic oncology surgeon with board certification in Gynecologic Oncology Surgery (2011) and extensive clinical experience, currently practicing with Acibadem Health Group since 2020. His work focuses on surgical care for gynecologic cancers, with particular expertise in minimally invasive and robotic techniques. He is an active member of numerous national and international professional societies, including the European Society of Gynaecological Oncology, Society of Gynecologic Oncology, International Gynecologic Cancer Society, and several robotic and minimally invasive surgery organizations. He also participates in regional and specialty groups such as the Turkish Obstetrics and Gynecology Association, Turkish Society of Gynecologic Oncology, Middle East and Mediterranean Association of Gynecologic Oncologists, Cervical Pathologies and Colposcopy Society, and the Trophoblastic Diseases Association. Prof. Köse is committed to advancing surgical practice through education, research, and collaboration across European, regional, and global networks, with a strong emphasis on improving patient outcomes through modern surgical approaches.

Education

  • 2011 Board of Medical Specialization Gynecologic Oncology Surgery
  • 1988 Ankara University Faculty of Medicine Gynecology and Obstetrics
  • 1981 Hacettepe University Faculty of Medicine

Experience

  • 2020 Acibadem Health Group
  • 2014 – 2016 Medipol Mega University Hospital / Obstetrics and Gynecology / Gynecologic Oncology Surgery Specialist
  • 2012 – 2014 LIV Hospital Ulus / Gynecology and Obstetrics Clinical Director
  • 2011 – 2012 Universal Italian Giovanni Alberto Agnelli Hospital / Medical Director
  • 2005 – 2011 Gynecologic Oncology Clinic / Clinic Chief, Etlik Zübeyde Hanım Gynecology Training and Research Hospital
  • 1992 – 2005 Ankara Maternity and Gynecology Training Hospital Gynecologic Oncology Clinic / Clinic Chief
  • 1988 – 1992 Ankara Maternity and Gynecology Training Hospital / Specialist Physician
  • 1981 – 1983 Ankara Sugar Factory / General Practitioner

Memberships

  • European Society of Gynaecological Oncology
  • Senalogy Academy
  • Society of Gynecologic Oncology
  • South Eastern European Robotic Surgery Society
  • Minimally Invasive Gynecologic Oncology Society
  • New European Surgical Academy
  • Cervical Pathologies and Colposcopy Society
  • Turkish Obstetrics and Gynecology Association
  • Turkish Society of Gynecologic Oncology
  • Middle East and Mediteranean Association of Gynecologic Oncologist
  • Robotic Gynecologic Surgery Association
  • Turkish German Gynecology Education, Research and Service Foundation
  • Turkish Medical Association
  • International Gynecologic Cancer Society
  • Trophoblastic Diseases Association
  • Society of European Robotic Gynecologic Surgery

Publications

  • Prognostic Factors in Adult Granulosa Cell Tumor: A Long Follow-Up at a Single Center.
    Int J Gynecol Cancer. 2016 May;26(4):619-25. Karalok A, Turan T, Ureyen I, Tasci T, Basaran D, Koc S, Boran N, Kose MF, Tulunay G
  • Management of cervical cancer during pregnancy.
    J Obstet Gynaecol. 2016 Apr;36(3):366-71. Gungorduk K, Sahbaz A, Ozdemir A, Gokcu M, Sancı M, Köse MF.
  • Lymphadenectomy should be performed up to the renal vein in patients with intermediate-high risk endometrial cancer.
    Pathol Oncol Res. 2015 Jul;21(3):803-10. Alay I, Turan T, Ureyen I, Karalok A, Tasci T, Ozfuttu A, Kose MF, Tulunay G.
  • Malignant transformation of mature cystic teratoma of the ovary: a case series.
    J Exp Ther Oncol. 2015;11(1):11-6. Koc S, Tapisiz OL, Turan T, Ocalan R, Ozfuttu A, Boran N, Kose MF, Tulunay HG.
  • Clinical outcomes of uterine carcinosarcoma: results of 94 patients.
    Int J Gynecol Cancer. 2015 Feb;25(2):279-87. Gokce ZK, Turan T, Karalok A, Tasci T, Ureyen I, Ozkaya E, Kose MF, Tulunay G.
  • Early and Late Complications after Inguinofemoral Lymphadenectomy for Vulvar Cancer.
    Asian Pac J Cancer Prev. 2015;16(13):5175-9. Cirik DA, Karalok A, Ureyen I, Tasci T, Kalyoncu R, Turkmen O, Kose MF, Tulunay G, Turan T.
  • Does Lymphadenectomy Improve Survival in Uterine Leiomyosarcoma?
    Int J Gynecol Cancer. 2015 Jul;25(6):1031-6. Tasci T, Karalok A, Taskin S, Ureyen I, Kımyon G, Tulek F, Ozfuttu A, Turan T, Tulunay G, Kose MF, Ortac F.
  • Risk for malignant and borderline ovarian neoplasms following basic preoperative evaluation by ultrasonography, Ca125 level and age.
    Asian Pac J Cancer Prev. 2014;15(19):8489-93. Karadag B, Kocak M, Kayikcioglu F, Ercan F, Dilbaz B, Kose MF, Haberal A.
  • Addition of epirubicin to conventional chemotherapy in patients with advanced ovarian cancer: sequential therapy -a retrospective evaluation.
    Turk J Med Sci. 2014;44(2):212-9. Özgül N, Köse MF, Keskin HL, Turan AT, Karalök MA, Üreyen I, Borani N, Tulunay HG.
  • What is the importance of omental metastasis in patients with endometrial cancer?
    J Turk Ger Gynecol Assoc. 2014 Aug 8;15(3):164-72. Turan T, Ureyen I, Karalök A, Tasci T, Ilgin H, Keskin L, Kose MF, Tulunay G.




×
Logo

29 hospitals and 15 medical centers in 5 countries.

About Us
Hospitals
Treatments
Doctors
Medical Technologies
Check Up Packages
Appointment
Blog
Health Library
Contact Us
Promotional
About Us

At ACIBADEM Healthcare Group, we are committed to healthcare excellence and providing world-class healthcare services to our patients. As a leader in international healthcare, we strive to deliver the highest quality of care and meet the needs of our diverse patient population.

Read More...
Appointment FormLive Support
Manage your privacy

We use technologies like cookies to store and/or access device information. We do this to improve browsing experience and to show (non-) personalized ads. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional
Always active
Preferences
Statistics